Trials / Recruiting
RecruitingNCT05523245
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,700 (estimated)
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Establish a deep learning model based on multi-parameter magnetic resonance imaging to predict the efficacy of neoadjuvant therapy for locally advanced rectal cancer.This study intends to combine DCE with conventional MRI images for DL, establish a multi-parameter MRI model for predicting the efficacy of CRT, and compare it with the DL and non-artificial quantitative MRI diagnostic model constructed by conventional MRI to evaluate the role of DL in MRI predicting CRT. And this study also tries to build a DL platform to assess the efficacy of LARC neoadjuvant radiotherapy and chemotherapy, accurately assess patients' complete respose (pCR) after CRT, and provide an important basis for guiding clinical decision-making.
Conditions
Timeline
- Start date
- 2022-06-24
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2022-08-31
- Last updated
- 2025-06-04
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05523245. Inclusion in this directory is not an endorsement.